Clinical trial
Qatar Cardiovascular Biorepository-AF (QCBio-AF) Study
NCT03660696 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Qatar Cardiovascular Biorepository-AF (QCBio-AF) Study
- Lead sponsor
- Hamad Medical Corporation
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 31, 2019
- Completion date
- December 31, 2020
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.